Table: Sinphar Pharmaceutical Apr Rev NT$291.5M Vs NT$271.0M

About this update from Sinphar Pharmaceutical Co. Ltd.

Sinphar Pharmaceutical Co. Ltd. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$291,461,000 NT$270,985,000 Jan-Apr Revenue NT$1,117,697,000 NT$1,076,707,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to [email protected].

View stock analysis, news, and events for Sinphar Pharmaceutical Co. Ltd.